By utilising an integrated approach that combines DEG analysis, correlation and co-expression analysis, and tissue-specific expression information, this study identified novel key genes, such as GSX1, SOX11, LILRB4, and NCAM1, which may be crucial players in the GBM mechanism making them promising targets for therapeutic strategies. The gene discussed is NCAM1; the disease is glioblastoma.